| HIG |
Report |
BI Underlying Combined Ratio (Q2 2026) |
IN-LINE |
pred ~88.1% vs. cons 88.43% |
MEDIUM |
| HIG |
Report |
Group Benefits Core Earnings Margin (Q2 2026) |
MISS |
pred ~7.8% vs. cons 8.09% |
MEDIUM |
| HIG |
Report |
Net Investment Income (Q2 2026) |
MISS |
pred ~$720M vs. cons $729M |
MEDIUM |
| HIG |
Guide |
FY 2026 Operating EPS (FY 2026) |
UNCHANGED |
guide ~$12.40 reaffirmed vs. cons $12.40; implied H2 math is a cut |
MEDIUM |
| HIG |
Guide |
FY 2026 NII (FY 2026) |
LOWER |
guide softened vs. cons $3.02B; LP headwinds acknowledged |
MEDIUM |
| HIG |
Guide |
Group Benefits Margin (FY 2026) |
LOWER |
guide toward lower end of 6-7% range vs. cons 7.53% |
MEDIUM |
| HIG |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.5% |
— |
MEDIUM |
| HIG |
Return |
5-day cumulative residual |
-3.5% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — sell-side cuts Q3/Q4 estimates as implied H2 math forces revisions lower; EB and NII misses pull FY consensus from $12.40 toward $12.10-12.20 |
MEDIUM |